Munshi, N. C. et al. Idecabtagene vicleucel in relapsed and refractory multiple myeloma. N. Engl. J. Med. 384, 705–716 (2021).

Article  CAS  PubMed  Google Scholar 

Rodriguez-Otero, P. et al. Ide-cel or standard regimens in relapsed and refractory multiple myeloma. N. Engl. J. Med. 388, 1002–1014 (2023).

Article  CAS  PubMed  Google Scholar 

San-Miguel, J. et al. Cilta-cel or standard care in lenalidomide-refractory multiple myeloma. N. Engl. J. Med. 389, 335–347 (2023).

Article  CAS  PubMed  Google Scholar 

Shah, N., Chari, A., Scott, E., Mezzi, K. & Usmani, S. Z. B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches. Leukemia 34, 985–1005 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Parikh, R. H. & Lonial, S. Chimeric antigen receptor T-cell therapy in multiple myeloma: a comprehensive review of current data and implications for clinical practice. CA Cancer J. Clin. 73, 275–285 (2023).

Article  PubMed  Google Scholar 

Morris, E. C., Neelapu, S. S., Giavridis, T. & Sadelain, M. Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy. Nat. Rev. Immunol. 22, 85–96 (2022).

Article  CAS  PubMed  Google Scholar 

Hamilton, M. P. et al. Risk of second tumors and T-cell lymphoma after CAR T-cell therapy. N. Engl. J. Med. 390, 2047–2060 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elsallab, M. et al. Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting System. Blood 143, 2099–2105 (2024).

Article  CAS  PubMed  Google Scholar 

Kobbe, G. et al. Aggressive lymphoma after CD19 CAR T-cell therapy. N. Engl. J. Med. 391, 1217–1226 (2024).

Article  CAS  PubMed  Google Scholar 

Ozdemirli, M. et al. Indolent CD4+ CAR T-cell lymphoma after cilta-cel CAR T-cell therapy. N. Engl. J. Med. 390, 2074–2082 (2024).

Article  CAS  PubMed  Google Scholar 

Ghilardi, G. et al. T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nat. Med. 30, 984–989 (2024).

Article  CAS  PubMed  Google Scholar 

Levine, B. L. et al. Unanswered questions following reports of secondary malignancies after CAR-T cell therapy. Nat. Med. 30, 338–341 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chari, A. et al. Talquetamab, a T-cell-redirecting GPRC5D bispecific antibody for multiple myeloma. N. Engl. J. Med. 387, 2232–2244 (2022).

Article  CAS  PubMed  Google Scholar 

Moignet, A. & Lamy, T. Latest advances in the diagnosis and treatment of large granular lymphocytic leukemia. Am. Soc. Clin. Oncol. Educ. Book 38, 616–625 (2018).

Article  PubMed  Google Scholar 

Muhowski, E. M. & Rogers, L. M. Dual TCR-expressing T cells in cancer: how single-cell technologies enable new investigation. Immunohorizons 7, 299–306 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wiestner, A. et al. Differential gene expression in CLL cells from bone marrow and peripheral blood suggests a role of bone marrow stroma in leukemic cell proliferation. Blood 106, 708 (2005).

Article  Google Scholar 

Sakhinia, E. et al. Comparison of gene-expression profiles in parallel bone marrow and peripheral blood samples in acute myeloid leukaemia by real-time polymerase chain reaction. J. Clin. Pathol. 59, 1059–1065 (2006).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huuhtanen, J. et al. Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia. Nat. Commun. 13, 1981 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Mel, S., Hue, S. S.-S., Jeyasekharan, A. D., Chng, W.-J. & Ng, S.-B. Molecular pathogenic pathways in extranodal NK/T cell lymphoma. J. Hematol. Oncol. 12, 33 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).

Article  CAS  PubMed  Google Scholar 

Hoffmann, S. et al. A multi-split mapping algorithm for circular RNA, splicing, trans-splicing and fusion detection. Genome Biol.15, R34 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Liu, L., McBride, K. M. & Reich, N. C. STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-α3. Proc. Natl Acad. Sci. USA 102, 8150–8155 (2005).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang, Y.-H. et al. Genomic and transcriptomic profiling of peripheral T cell lymphoma reveals distinct molecular and microenvironment subtypes. Cell Rep. Med. 5, 101416 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheon, H. et al. Genomic landscape of TCRαβ and TCRγδ T-large granular lymphocyte leukemia. Blood 139, 3058–3072 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lone, W., Alkhiniji, A., Manikkam Umakanthan, J. & Iqbal, J. Molecular insights into pathogenesis of peripheral T cell lymphoma: a review. Curr. Hematol. Malig. Rep. 13, 318–328 (2018).

Article  PubMed  Google Scholar 

Antoni, L., Sodha, N., Collins, I. & Garrett, M. D. CHK2 kinase: cancer susceptibility and cancer therapy – two sides of the same coin? Nat. Rev. Cancer 7, 925–936 (2007).

Article  CAS  PubMed  Google Scholar 

Gan, X. et al. PRR5L degradation promotes mTORC2-mediated PKC-δ phosphorylation and cell migration downstream of Gα12. Nat. Cell Biol. 14, 686–696 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Greenplate, A. et al. Genomic profiling of T-Cell neoplasms reveals frequent JAK1 and JAK3 mutations with clonal evasion from targeted therapies. JCO Precis. Oncol. 2, 1–16 (2018).

Article  Google Scholar 

Wahnschaffe, L. et al. JAK/STAT-activating genomic alterations are a hallmark of T-PLL. Cancers 11, 1833 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alaggio, R. et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 36, 1720–1748 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Sandberg, Y. et al. Lack of common TCRA and TCRB clonotypes in CD8(+)/TCRαβ(+) T-cell large granular lymphocyte leukemia: a review on the role of antigenic selection in the immunopathogenesis of CD8(+) T-LGL. Blood Cancer J. 4, e172 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marchand, T., Lamy, T. & Loughran, T. P.